As industry innovators seek to master the growing injectables market, partnering across disciplines helps overcome regulatory and practical challenges.
The vial-to-syringe story in pharmaceutical packaging and delivery is well known. There is no doubt that the advent and swift advancement of safe, convenient, and versatile drug delivery systems (think pre-filled syringes to pens and on-body delivery options) is game changing. Yet, if you are a drug developer, high-tech devices and delivery systems add complexity to your job of creating a safe, effective therapeutic.
With growing demand for combination products, the device, components, packaging and regulatory filings also make way into your camp. That’s a lot. It is this space where device and drug makers are coming together. Development service providers help drug developers connect with the industry counterparts relevant to each journey—thus streamlining the path to market by ensuring expert direction every step of the way.
A recent Healthcare Packaging article unpacks the trends, standards and partnerships that are emerging as a result of the combination product market complexities. By joining with experts to tackle each major facet of development, compatibility between therapeutic, packaging and delivery device can be addressed early on, for a smooth(er) process.
